Revlimid (lenalidomide) Patient Assistance Program
Don’t let the high cost of brand lenalidomide disrupt your multiple myeloma, lymphoma, or MDS treatment. We help eligible patients access Revlimid (lenalidomide capsules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program — or via the widely available generic.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Revlimid (lenalidomide) is FDA-approved across multiple hematologic malignancies: multiple myeloma (with dexamethasone for newly diagnosed, and post-autologous SCT maintenance), transfusion-dependent anemia in low- or intermediate-1 risk MDS with del(5q) chromosomal abnormality, mantle cell lymphoma (after ≥2 prior therapies including bortezomib), follicular lymphoma (with rituximab; R² regimen), marginal zone lymphoma (with rituximab). Second-generation immunomodulatory drug (IMiD) — thalidomide analog with improved potency and tolerability.
- Without assistance, brand Revlimid costs commonly run approximately $18,000–$22,000 per month.
- Through AffordMyPrescriptions, qualifying patients can access Revlimid for a flat $69.95 per month.
- Generic lenalidomide widely available — substantial cost reduction (often $2,000–$8,000/month depending on strength and pharmacy). Other IMiDs: pomalidomide (Pomalyst), thalidomide (Thalomid — generic available). Other MM therapies: proteasome inhibitors (bortezomib generic, carfilzomib/Kyprolis, ixazomib/Ninlaro oral), anti-CD38 antibodies (daratumumab IV/SC, isatuximab/Sarclisa), CAR-T (Carvykti, Abecma), bispecific antibodies (Tecvayli, Talvey, Elrexfio), selinexor (Xpovio). REMS program required due to teratogenicity.
What is Revlimid Prescription Assistance Program?
The Revlimid Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Revlimid (used across multiple hematologic malignancies as an immunomodulatory drug) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, hematology/oncology coordination, indication-specific documentation, REMS program enrollment, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing a hematologic malignancy.
At AffordMyPrescriptions, our Patient Advocates handle the entire Revlimid PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your oncologist for required medical documentation, follow up with the manufacturer’s program until approval, coordinate REMS pregnancy testing and monthly compliance, manage your refills, and handle annual re-certification — so you never face a gap in your Revlimid IMiD therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Revlimid enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your hematologic malignancy treatment.
Pharmacy Price Comparison
- Without assistance, brand Revlimid costs thousands of dollars per month at specialty pharmacies. Generic lenalidomide is now widely available at substantially lower cost. Discount cards and pharmacy coupons offer some relief, but a Patient Assistance Program can further reduce cost. The table below compares typical retail pricing across major pharmacies to what you'd pay with our Revlimid advocacy service:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Pomalidomide (Pomalyst — alt) | ~$22,000/mo | Alt 3rd-gen IMiD for R/R MM |
| Walgreens (brand) | ~$21,500/mo | Save substantially |
| CVS Pharmacy (brand) | ~$22,000/mo | Save substantially |
| Walmart (brand) | ~$19,000/mo | Save substantially |
| Specialty pharmacy (brand) | ~$18,000/mo | Save substantially |
| Generic lenalidomide | ~$4,000/mo | Generic — substantial |
Generic lenalidomide widely available — substantial cost reduction (often $2,000–$8,000/month depending on strength and pharmacy). Other IMiDs: pomalidomide (Pomalyst — third-generation IMiD for relapsed/refractory multiple myeloma), thalidomide (Thalomid — original, generic available). Other MM therapies: proteasome inhibitors (bortezomib generic, carfilzomib/Kyprolis, ixazomib/Ninlaro oral), anti-CD38 antibodies (daratumumab IV/SC, isatuximab/Sarclisa), CAR-T (Carvykti, Abecma), bispecific antibodies (Tecvayli, Talvey, Elrexfio), selinexor (Xpovio). REMS program required due to teratogenicity — mandatory pregnancy testing and effective contraception in patients of childbearing potential.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Revlimid Prescription Program?
The Revlimid Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, REMS pregnancy compliance, refill management, and re-enrollment — so you focus on your health, not paperwork. Generic lenalidomide now widely available substantially cheaper.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Revlimid assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Revlimid is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Revlimid:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $18,000–$22,000 brand / $2,000–$8,000 generic per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Revlimid assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Revlimid Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Revlimid:
Revlimid is a second-generation immunomodulatory drug (IMiD) — improved potency and reduced neurotoxicity vs original thalidomide. Multiple hematologic malignancy indications including newly diagnosed and maintenance multiple myeloma, del(5q) MDS-associated anemia, mantle cell lymphoma, and follicular/marginal zone lymphoma (with rituximab as R²). Mechanism involves cereblon binding and multiple downstream immunomodulatory and anti-tumor effects.
How It Works:
Immunomodulatory drugs (IMiDs) — thalidomide, lenalidomide, pomalidomide — bind cereblon (CRBN), a substrate receptor of the CRL4 E3 ubiquitin ligase complex. This binding alters the ligase’s substrate specificity, promoting degradation of specific transcription factors including IKZF1 (Ikaros) and IKZF3 (Aiolos) that drive multiple myeloma cell survival. Lenalidomide’s mechanism includes: direct tumor cell apoptosis (multiple myeloma, lymphomas), stimulation of T-cell and NK cell anti-tumor activity, inhibition of angiogenesis, modulation of cytokine production, and modulation of stromal cell support of tumors. In del(5q) MDS, lenalidomide specifically targets abnormal erythroid clones. Effective across multiple hematologic malignancies with different treatment durations and combinations.
Form and Use:
Revlimid capsules in multiple strengths (2.5, 5, 10, 15, 20, 25 mg). Dosing varies by indication and renal function: multiple myeloma with dexamethasone: 25 mg daily days 1–21 of 28-day cycles; MM maintenance post-SCT: 10 mg daily continuously; del(5q) MDS: 10 mg daily; mantle cell lymphoma: 25 mg daily days 1–21 of 28-day cycles; follicular/marginal zone lymphoma with rituximab: 20 mg daily days 1–21 of 28-day cycles for up to 12 cycles. Take with or without food. REMS program participation mandatory: pregnancy testing before each cycle, monthly compliance, effective contraception (two forms — one highly effective plus one barrier) in patients of childbearing potential; no blood/sperm donation. Anticoagulation (aspirin, LMWH, or DOAC) recommended for VTE prophylaxis.
Generic Availability:
Generic lenalidomide widely available — substantial savings vs brand Revlimid. Same REMS program applies to generic. Other IMiDs: pomalidomide (Pomalyst — third-generation IMiD, for relapsed/refractory multiple myeloma; no generic yet), thalidomide (Thalomid — original IMiD, generic available; older with more neurotoxicity). Other multiple myeloma therapies: proteasome inhibitors (bortezomib/Velcade generic; carfilzomib/Kyprolis; ixazomib/Ninlaro oral weekly), anti-CD38 monoclonal antibodies (daratumumab/Darzalex IV and Darzalex Faspro SC; isatuximab/Sarclisa IV), CAR-T cell therapy (Abecma; Carvykti), bispecific antibodies (teclistamab/Tecvayli; talquetamab/Talvey; elranatamab/Elrexfio), selinexor (Xpovio), elotuzumab (Empliciti), belantamab mafodotin (Blenrep). Standard supportive care: dexamethasone (generic), bisphosphonates or denosumab (Xgeva) for bone health, antiviral and PCP prophylaxis. Allogeneic SCT for select patients. For MDS: azacitidine (generic), decitabine (generic and oral Inqovi), Reblozyl (luspatercept). For lymphomas: rituximab biosimilars, bendamustine, other chemoimmunotherapy backbones.
Warnings:
Boxed warnings: embryo-fetal toxicity (lenalidomide is analog of thalidomide, known human teratogen causing severe birth defects — mandatory REMS program with pregnancy testing before and monthly during therapy; effective contraception in patients of childbearing potential — two forms required; no sperm or blood donation), hematologic toxicity (severe cytopenias — neutropenia, thrombocytopenia, anemia — monitor CBC weekly first 8 weeks then monthly; may require dose reduction or interruption), venous and arterial thromboembolism (DVT, PE, MI, stroke — significantly increased risk especially with dexamethasone combinations; VTE prophylaxis required based on risk). Other: increased mortality with pembrolizumab combination in myeloma (contraindicated), increased second primary malignancies (long-term follow-up), hepatotoxicity, severe cutaneous reactions including SJS/TEN, tumor lysis syndrome, tumor flare reaction, impaired stem cell mobilization, thyroid disorders. Renal dose adjustment essential. Live vaccines avoided.
FAQ (Frequently Asked Questions)
How much does Revlimid cost without insurance?
Brand Revlimid $18,000–$22,000 per month. Generic lenalidomide now widely available — typically $2,000–$8,000 per month depending on strength and pharmacy — substantial cost reduction.
Is brand Revlimid better than the generic version?
Generic lenalidomide is FDA-approved bioequivalent to brand Revlimid. Same active ingredient, same effect, same safety profile, same REMS program requirements. Most patients can use the generic without clinical difference at substantial cost savings.
What is the REMS program and why is it required for Revlimid?
Revlimid is an analog of thalidomide — a known human teratogen causing severe birth defects. REMS (Risk Evaluation and Mitigation Strategy) mandates: pregnancy testing before starting therapy, before each cycle, and periodically; effective contraception in patients of childbearing potential (two forms required); no sperm or blood donation; monthly compliance verification. Applies to generic lenalidomide equally.
Why is VTE prophylaxis needed with Revlimid?
Lenalidomide significantly increases venous and arterial thromboembolism risk — especially in combination with dexamethasone or other therapies. VTE prophylaxis (aspirin 81–325 mg daily for low-risk; LMWH or DOAC for higher-risk) is standard of care based on individual VTE risk assessment. Discuss with your hematologist.
How is Revlimid used across multiple myeloma treatment phases?
Multiple applications: (1) induction (RVd = Revlimid + Velcade + dexamethasone for newly diagnosed MM); (2) maintenance after autologous stem cell transplant (single-agent lenalidomide continuously until progression); (3) relapsed/refractory (in various triplet/quadruplet combinations with anti-CD38 antibodies, proteasome inhibitors, and dexamethasone). Long-term therapy is common — often continuous for years.
Take Control of Your Medication Costs
IMiD therapy for hematologic malignancies should not be derailed by cost. Generic lenalidomide now widely available at substantial savings vs brand Revlimid. Our Revlimid advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, REMS compliance, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Revlimid through a Patient Assistance Program, you are not charged.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.